CV Therapeutics Earnings Overshadows Takeover Spec

Posted: July 31, 2007 at 1:45 pm

Print Email


Posted by Thomas Catino

Ant&Sons

Shares of CV Therapeutics Inc. (CVTX) are slumping, down $.60, or 5.52%, to $10.26 on moderate volume. It’s been a volatile ride for the stock that is continuing this morning after the company posted…continued
RSS Facebook Twitter
Read more: General,